131 related articles for article (PubMed ID: 11903817)
1. The unexplained survival of cells in oral cancer: what is the role of p53?
Whyte DA; Broton CE; Shillitoe EJ
J Oral Pathol Med; 2002 Mar; 31(3):125-33. PubMed ID: 11903817
[TBL] [Abstract][Full Text] [Related]
2. Different patterns of expression of cell cycle control and local invasion-related proteins in oral squamous cell carcinoma affecting young patients.
Miranda Galvis M; Santos-Silva AR; Freitas Jardim J; Paiva Fonseca F; Lopes MA; de Almeida OP; Lópes Pinto CA; Kaminagakura E; Sawazaki-Calone I; Speight PM; Kowalski LP
J Oral Pathol Med; 2018 Jan; 47(1):32-39. PubMed ID: 28626969
[TBL] [Abstract][Full Text] [Related]
3. Expression of p21/waf1 in oral squamous cell carcinomas--correlation with p53 and mdm2 and cellular proliferation index.
Ng IO; Lam KY; Ng M; Regezi JA
Oral Oncol; 1999 Jan; 35(1):63-9. PubMed ID: 10211312
[TBL] [Abstract][Full Text] [Related]
4. Apoptosis-associated proteins and the development of oral squamous cell carcinoma.
Schoelch ML; Le QT; Silverman S; McMillan A; Dekker NP; Fu KK; Ziober BL; Regezi JA
Oral Oncol; 1999 Jan; 35(1):77-85. PubMed ID: 10211314
[TBL] [Abstract][Full Text] [Related]
5. p53, mdm2, and p21 expression in oral squamous cell carcinomas: relationship with clinicopathologic factors.
Yanamoto S; Kawasaki G; Yoshitomi I; Mizuno A
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2002 Nov; 94(5):593-600. PubMed ID: 12424454
[TBL] [Abstract][Full Text] [Related]
6. The influence of p53 and associated factors on the outcome of patients with oral squamous cell carcinoma.
Stoll C; Baretton G; Löhrs U
Virchows Arch; 1998 Nov; 433(5):427-33. PubMed ID: 9849857
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the chemosensitivity of head and neck cancer cells based on the diverse function of mutated-p53.
Shinagawa Y; Kawamata H; Omotehara F; Nakashiro K; Hoque MO; Furihata T; Horiuchi H; Imai Y; Fujimori T; Fujibayashi T
Int J Oncol; 2003 Feb; 22(2):383-9. PubMed ID: 12527938
[TBL] [Abstract][Full Text] [Related]
8. Subtype-selective induction of wild-type p53 and apoptosis, but not cell cycle arrest, by human somatostatin receptor 3.
Sharma K; Patel YC; Srikant CB
Mol Endocrinol; 1996 Dec; 10(12):1688-96. PubMed ID: 8961277
[TBL] [Abstract][Full Text] [Related]
9. RT-PCR amplification of RNA extracted from formalin-fixed, paraffin-embedded oral cancer sections: analysis of p53 pathway.
Tachibana M; Shinagawa Y; Kawamata H; Omotehara F; Horiuchi H; Ohkura Y; Kubota K; Imai Y; Fujibayashi T; Fujimori T
Anticancer Res; 2003; 23(3C):2891-6. PubMed ID: 12926130
[TBL] [Abstract][Full Text] [Related]
10. p53, p16 and cyclin D1: molecular determinants of radiotherapy treatment response in oral carcinoma.
Jayasurya R; Francis G; Kannan S; Lekshminarayanan K; Nalinakumari KR; Abraham T; Abraham EK; Nair MK
Int J Cancer; 2004 May; 109(5):710-6. PubMed ID: 14999779
[TBL] [Abstract][Full Text] [Related]
11. MDM2 overexpression with alteration of the p53 protein and gene status in oral carcinogenesis.
Li XJ; Murai M; Koyama T; Wang DY; Hashimoto K
Jpn J Cancer Res; 2000 May; 91(5):492-8. PubMed ID: 10835493
[TBL] [Abstract][Full Text] [Related]
12. Expression of apoptotic signaling proteins in leukoplakia and oral lichen planus: quantitative and topographical studies.
Tanda N; Mori S; Saito K; Ikawa K; Sakamoto S
J Oral Pathol Med; 2000 Sep; 29(8):385-93. PubMed ID: 10972347
[TBL] [Abstract][Full Text] [Related]
13. Human papillomavirus infection in Egyptian esophageal carcinoma: correlation with p53, p21, mdm2, C-erbB2 and impact on survival.
Bahnassy AA; Zekri AR; Abdallah S; El-Shehaby AM; Sherif GM
Pathol Int; 2005 Feb; 55(2):53-62. PubMed ID: 15693850
[TBL] [Abstract][Full Text] [Related]
14. Alterations in p53 and pRb pathways and their prognostic significance in oesophageal cancer.
Mathew R; Arora S; Khanna R; Mathur M; Shukla NK; Ralhan R
Eur J Cancer; 2002 Apr; 38(6):832-41. PubMed ID: 11937319
[TBL] [Abstract][Full Text] [Related]
15. Expression of p53, mdm2, p21/waf1 and bcl-2 proteins in thymomas.
Stefanaki K; Rontogianni D; Kouvidou CH; Bolioti S; Delides G; Pantelidaki A; Sotsiou F; Kanavaros P
Histopathology; 1997 Jun; 30(6):549-55. PubMed ID: 9205859
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical expression of mdm2 and p21WAF1 in invasive cervical cancer: correlation with p53 protein and high risk HPV infection.
Troncone G; Martinez JC; Palombini L; De Rosa G; Mugica C; Rodriguez JA; Zeppa P; Di Vizio D; Lucariello A; Piris MA
J Clin Pathol; 1998 Oct; 51(10):754-60. PubMed ID: 10023338
[TBL] [Abstract][Full Text] [Related]
17. TP53 alterations in relation to the cell cycle-associated proteins p21, cyclin D1, CDK4, RB, MDM2, and EGFR in cancers of the uterine corpus.
Skomedal H; Kristensen GB; Nesland JM; Børresen-Dale AL; Tropé C; Holm R
J Pathol; 1999 Apr; 187(5):556-62. PubMed ID: 10398121
[TBL] [Abstract][Full Text] [Related]
18. Comparative analysis of the expression of proliferating cell nuclear antigen, p53, bax, and bcl-2 in oral lichen planus and oral squamous cell carcinoma.
de Sousa FA; Paradella TC; Carvalho YR; Rosa LE
Ann Diagn Pathol; 2009 Oct; 13(5):308-12. PubMed ID: 19751907
[TBL] [Abstract][Full Text] [Related]
19. Abnormalities of molecular regulators of proliferation and apoptosis in carcinoma of the oral cavity and oropharynx.
Kuropkat C; Venkatesan TK; Caldarelli DD; Panje WR; Hutchinson J; Preisler HD; Coon JS; Werner JA
Auris Nasus Larynx; 2002 Apr; 29(2):165-74. PubMed ID: 11893452
[TBL] [Abstract][Full Text] [Related]
20. p53 and MDM2 expression in oral squamous cell carcinoma.
Matsumura T; Yoshihama Y; Kimura T; Shintani S; Alcalde RE
Oncology; 1996; 53(4):308-12. PubMed ID: 8692535
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]